MERIT MEDICAL SYSTEMS INC (MMSI)
US5898891040 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to MMSI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 95.47. This target is 20.9% above the current price.
MMSI was analyzed by 16 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MMSI.
In the previous month the buy percentage consensus was at a similar level.
MMSI was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-01 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-05-01 | Needham | Maintains | Buy -> Buy |
| 2024-05-01 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-04-16 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-04-11 | CL King | Initiate | Buy |
| 2024-04-11 | Needham | Reiterate | Buy -> Buy |
| 2024-02-29 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-02-29 | Needham | Maintains | Buy -> Buy |
| 2024-02-29 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-02-29 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-02-07 | B of A Securities | Initiate | Neutral |
| 2024-01-30 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-01-12 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-12-21 | Canaccord Genuity | Upgrade | Hold -> Buy |
| 2023-10-27 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-10-27 | Needham | Maintains | Buy -> Buy |
| 2023-09-27 | Needham | Reiterate | Buy -> Buy |
| 2023-08-28 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2023-08-16 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2023-07-26 | Needham | Reiterate | Buy -> Buy |
| 2023-07-21 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-07-06 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2023-06-09 | Barrington Research | Maintains | Outperform |
| 2023-06-09 | Needham | Maintains | Buy -> Buy |
| 2023-05-08 | Raymond James | Maintains | Outperform |
| 2023-04-27 | Barrington Research | Maintains | Outperform |
| 2023-04-27 | Needham | Maintains | Buy |
| 2023-04-27 | Wells Fargo | Maintains | Equal-Weight |
| 2023-04-27 | Raymond James | Maintains | Outperform |